SO ERIC H. L. enters HELUS PHARMA INC. with 4.22M shares plus derivative instruments
Holding both equity and derivatives at entry signals strong long-term conviction in the company.
Direct Indirect Derivatives
Filed: 9/9/2026ACC: 0000912282-26-001253
DirectorOfficer· Executive Chair
Since Sep 2026
4.22M
Baseline shares
99% direct
4.17M
Direct ownership
1 position
105.26K
Derivative underlying
1 instrument
2
Security positions
53.62K indirect
Non-Derivative Holdings2
Common Shares
IndirectShares owned53.62K
Common Shares
DirectShares owned4.17M
Total
4.17M direct·53.62K indirect4.22M
| Security Title | Shares Owned | Ownership Type |
|---|---|---|
| Common Shares | 53.62K | Indirect |
| Common Shares | 4.17M | Direct |
| Total | 4.22M | 4.17M direct·53.62K indirect |
Derivative Holdings1
Warrants
DirectUnderlying security
Common Shares
Underlying shares
105.26K
Shares owned
N/A
Exercise price
Expiration
—
Exercise window
—
Total
Underlying
105.26K
Owned
0.00
| Security | Underlying | Exercise Price | Exercise Window | Expiration | Underlying Shares | Shares Owned |
|---|---|---|---|---|---|---|
| Warrants Direct | Common Shares | — | — | 105.26K | N/A | |
| Total | 105.26K | 0.00 | ||||